Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 28;8(1):78.
doi: 10.1186/s40792-022-01429-2.

Gastric cancer complicated by paraneoplastic neurological syndrome which presented with extremity numbness: a case report

Affiliations

Gastric cancer complicated by paraneoplastic neurological syndrome which presented with extremity numbness: a case report

Takuto Yoshida et al. Surg Case Rep. .

Abstract

Background: Paraneoplastic neurological syndromes refer to a group of neurological disorders, which occur as distant effects of malignant tumors and are not caused by metastasis, nutritional disorders, or side effects of antitumor drugs.

Case presentation: A 70-year-old woman complained of a 1-month history of extremity numbness. Upon presentation to our hospital, she had worsening numbness, and experienced staggering and falling. Physical examination revealed diminished tendon reflexes in both lower limbs, stocking and glove-type abnormal sensation, and left-sided dominant high-steppage gait due to weakness of the bilateral tibialis anterior muscles. Blood tests indicated anemia, and upper gastrointestinal endoscopy revealed gastric cancer, leading to laparoscopic distal gastrectomy. A nerve conduction velocity test showed demyelinating peripheral neuropathy. Further blood tests and imaging studies ruled out nutritional disorders, such as vitamin deficiency, diabetes-related diseases, connective tissue diseases, and central nervous system metastasis, leading to the suspicion of paraneoplastic neurological syndrome. After laparoscopic distal gastrectomy, the progression of symptoms stopped, and with intravenous high-dose immunoglobulin and steroid therapy, the symptoms improved to only minor numbness in the peripheral limbs as of the 18-month follow-up. As of the 2-year follow-up, there has been no cancer recurrence or metastasis.

Conclusions: When paraneoplastic neurological syndrome is suspected, early diagnosis and a multidisciplinary approach, including surgical treatment, are important before irreversible neurological damage occurs.

Keywords: Gastric cancer; Neurological disorder; Numbness; Paraneoplastic neurological syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Gastric fiber. Type 3 tumor in posterior wall of the lower part of the stomach
Fig. 2
Fig. 2
Magnetic resonance imaging. A Brain magnetic resonance imaging (MRI). Brain MRI shows multiple T2 high signals in the bilateral basal ganglia and cerebral white matter, indicating a chronic ischemic lesion. There is no evidence of brain metastasis. B Spinal MRI. C4 kyphosis and narrowing of the spinal canal of C4/5. No obvious spinal cord compression or abnormal signal is observed
Fig. 3
Fig. 3
Abdominal CT. There is irregular wall thickening with a contrast effect on the posterior wall of the lower stomach (yellow arrow). Multiple enlarged lymph nodes are observed on the greater curvature of the stomach (white arrow). No obvious distant metastasis is observed
Fig. 4
Fig. 4
Pathophysiology. A Pathological specimen. A 45 × 40 mm type 3 lesion was found 2.5 cm from the proximal margin and 7 cm from the distal margin. B Hematoxylin–Eosin double stain, × 20. Histologically, the lesion shows moderately to poorly differentiated adenocarcinoma

Similar articles

References

    1. Sano T, Kodera Y. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–112. doi: 10.1007/s10120-011-0040-6. - DOI - PubMed
    1. Posner JB, Dalmaut D. Paraneoplastic syndromes. Curr Opin Immunol. 1997;5:723–729. doi: 10.1016/S0952-7915(97)80055-6. - DOI - PubMed
    1. Tanaka K. Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies. Clin Neurol. 2010;50:371–378. - PubMed
    1. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–1140. doi: 10.1136/jnnp.2003.034447. - DOI - PMC - PubMed
    1. Inuzuka T, Hayashi Y, Kimura A. Pareneoplastic neurological syndrome–update. Rinsho shinkeigaku = Clin Neurol. 2011;51(11):834–837. doi: 10.5692/clinicalneurol.51.834. - DOI - PubMed